Webinar | RWD’s Value in Autoimmune Disease
RWD’s value in accelerating autoimmune disease diagnosis
Delayed diagnosis of autoimmune diseases is common due to subjective symptoms, lack of definitive testing, and gender bias. This delay can cause worsening symptoms and disease progression in individuals while simultaneously leading to missed research opportunities and reduced revenue for pharma.
Longitudinal real-world data (RWD) collected directly from individuals can help by giving you a comprehensive and objective picture of patients’ day-to-day experiences and quality of life. Watch our on-demand webinar to hear experts discuss how advancements in RWD can:
- Identify new markers for earlier detection, capturing individuals’ unique experiences
- Power AI tools for faster analysis, reducing delays and improving healthcare equity
- Collect data needed to inform health care provider discussions to support diagnosis
Related work
News
Evidation Launches Temporal Proteomics Platform to Power Autoimmune Research January 8, 2026
Evidation Shares Insights on Real-World GLP-1 Dosing Behaviors from Over 60,000 Individuals December 16, 2025
Evidation Appoints Dr. Ghazanfar Khan as Chief Medical Officer December 2, 2025
Related Therapeutic Areas:
Subscribe to our monthly business newsletter